TCT 793: Sex Specific Outcomes of Treating Patients with Refractory Angina with the Coronary Sinus Reducer: One-year outcomes from the REDUCER-I Registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Elixir</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Shockwave Medical</li><li>Consultant Fee/Honoraria/Speaker's Bureau - V-Wave</li></ul>